Corpus Intelligence Market Analysis — ST. CHARLES SURGICAL HOSPITAL 2026-04-26 11:20 UTC
Market Analysis — ST. CHARLES SURGICAL HOSPITAL
LA market | 5 hospitals | HHI: 4,785 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
5
Hospitals in Market
835
Total Beds
$1.2B
Market Revenue
Concentrated
HHI: 4,785
None
Moat Rating (0/10)
#3
Market Share Rank

Competitive Moat (Mauboussin Framework)

Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).

Scale Advantageweak
Switching Costslow
Market Share2.5%
Top 3 Concentration99.1%
Network Density0.60
Margin vs Market-0.0%
Bed Util vs Market-49.2%

What This Means

This hospital has a none moat — no moat — commoditized market position, pricing power limited. The LA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 4,785).

Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full LA market.

Top Competitors

HospitalBedsRevenueRev ShareBed Share
UNIVERSITY MEDICAL CTR. AT NEW ORLEA310$671M55.8%37.1%
TULANE UNIVERSITY HOSPITAL & CLINICS431$490M40.8%51.6%
BEACON BEHAVIORAL HOSPITAL N.O. INC34$8M0.7%4.1%
BLIANT SPRCIALTY HOSPITAL21$3M0.2%2.5%

Regional Payer Mix

■ Medicare 22%■ Medicaid 15%■ Commercial 63%